Optical coherence tomography in children with inherited retinal disease

Clin Exp Optom. 2024 Apr;107(3):255-266. doi: 10.1080/08164622.2023.2294807. Epub 2024 Jan 22.

Abstract

Recent advances have led to therapeutic options becoming available for people with inherited retinal disease. In particular, gene therapy has been shown to hold great promise for slowing vision loss from inherited retinal disease. Recent studies suggest that gene therapy is likely to be most effective when implemented early in the disease process, making consideration of paediatric populations important. It is therefore necessary to have a comprehensive understanding of retinal imaging in children with inherited retinal diseases, in order to monitor disease progression and to determine which early retinal biomarkers may be used as outcome measures in future clinical trials. In addition, as many optometrists will review children with an inherited retinal disease, an understanding of the expected imaging outcomes can improve clinical care. This review focuses on the most common imaging modality used in research assessment of paediatric inherited retinal diseases: optical coherence tomography. Optical coherence tomography findings can be used in both the clinical and research setting. In particular, the review discusses current knowledge of optical coherence tomography findings in eight paediatric inherited retinal diseases - Stargardt disease, Bests disease, Leber's congenital amaurosis, choroideremia, RPGR related retinitis pigmentosa, Usher syndrome, X-linked retinoschisis and, Batten disease.

Keywords: Inherited retinal disease; optical coherence tomography; paediatric; retinal imaging.

Publication types

  • Review

MeSH terms

  • Child
  • Eye Proteins
  • Humans
  • Retina / diagnostic imaging
  • Retinal Diseases* / diagnostic imaging
  • Retinal Diseases* / genetics
  • Stargardt Disease
  • Tomography, Optical Coherence*

Substances

  • RPGR protein, human
  • Eye Proteins